Details of the Drug

General Information of Drug (ID: DM6GKYF)

Drug Name
TTX-080
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Drug Type
Antibody
Cross-matching ID
TTD ID
D7J2NK

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
MHC class I antigen G (HLA-G) TTLKFB3 HLAG_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04485013) TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Tizona Therapeutics.